-
Zydus Cadila gets final US FDA nod for Solifenacin Succinate Tablets
expresspharma
October 22, 2020
There are used as a symptomatic treatment of urge incontinence and/or increased urinary frequency and urgency in patients with overactive bladder syndrome.
-
Zydus Cadila gets tentative USFDA nod for Tofacitinib ER tablets
expresspharma
October 21, 2020
Zydus Cadila has received tentative approval from the USFDA to market Tofacitinib Extended-Release Tablets, 11 mg (US RLD: Xeljanz XR Tablets).
-
Zydus Cadila gets US FDA approval for fingolimod capsules and verapamil hydrochloride injection
expresspharma
October 19, 2020
Fingolimod is an immunomodulating drug to treat multiple sclerosis and Verapamil injection is restore normal heartbeats in people with certain heart rhythm disorders.
-
Zydus Cadila gets final nod for Ursodiol capsules, tentative nod for Linagliptin and Metformin Hydrochloride tablets
expresspharma
October 19, 2020
Zydus Cadila has received final approval from the USFDA to market Ursodiol Capsules USP, 300 mg (US RLD: Actigall Capsules).
-
Zydus Cadila launches COPD drug in India
expresspharma
October 09, 2020
Forglyn pMDI is priced at Rs 495 per pack and has been developed in-house using Zydus’ innovations in formulation technology.
-
US FDA approves Zydus Cadila’s dimethyl fumarate DR capsules
expresspharma
September 27, 2020
These tablets will be manufactured at the group’s manufacturing facility at the SEZ, Matoda.
-
Zydus Cadila receives tentative USFDA approval for palbociclib capsules
expresspharma
September 27, 2020
It is an anti-cancer medicine that interferes with the growth and spread of cancer cells in the body.
-
Zydus Cadila gets US FDA nod for potassium chloride extended-release tablets
expresspharma
September 21, 2020
It is a mineral supplement used to treat or prevent low amounts of potassium in the blood.
-
Zydus Cadila gets tentative USFDA nod for empagliflozin and linagliptin tablets
expresspharma
September 18, 2020
They are oral diabetes medicines that help control blood sugar levels.
-
Zydus Cadila gets US FDA approval for Doxorubicin Hydrochloride Liposome Injection
expresspharma
September 14, 2020
Liposomal doxorubicin is a chemotherapeutic agent that is used alone or with other treatments/medications to treat certain types of cancer like ovarian cancer, AIDS-related Kaposi’s sarcoma and multiple myelom.